Search Results - Shengli Xia
- Showing 1 - 3 results of 3
-
1
A phase III clinical trial to evaluate the safety and immunogenicity of 23-valent pneumococcal polysaccharide vaccine (PPV23) in healthy children, adults, and elderly by Lili Huang, Ling Wang, Hong Li, Yuansheng Hu, Weiping Ru, Weixiao Han, Gang Shi, Qiang Ye, Zhen Han, Jielai Xia, Shengli Xia, Miao Xu, Jing Li
Published 2019Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
2
Safety, immunogenicity, and lot-to-lot consistency of live attenuated varicella vaccine in 1-3 years old children: a double-blind, randomized phase III trial by Lili Huang, Zhen Chen, Yuansheng Hu, Zhiqiang Xie, Ping Qiu, Lang Zhu, Manli Bao, Yaru Quan, Ji Zeng, Yanxia Wang, Xiaoyu Cui, Liyong Yuan, Shengli Xia, Fanhong Meng
Published 2019Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
3
Immunological non-inferiority and safety of a quadrivalent inactivated influenza vaccine versus two trivalent inactivated influenza vaccines in China: Results from two studies by Xiaoqiang Liu, Juliana Park, Shengli Xia, Bin Liang, Shuangmin Yang, Yanxia Wang, Olga Syrkina, Nathalie Lavis, Shuzhen Liu, Chenyan Zhao, Jian Ding, Jieqiong Hu, Sandrine I. Samson, Iris A. de Bruijn, for the FSQ01 and FSQ02 Study Groups
Published 2022Call Number: Loading…Connect to this object online.
Located: Loading…
Book